Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Genentech - Wikipedia

    en.wikipedia.org/wiki/Genentech

    Genentech was founded by venture capitalist Robert A. Swanson and biochemist Dr. Herbert W. Boyer. After a meeting in 1976, the two decided to start a biotechnology company, Genentech. Although the two confidently assert that it was the first biotech company, others clearly came before, including Cetus Corporation which was founded in 1971.

  3. Roche - Wikipedia

    en.wikipedia.org/wiki/Roche

    Genentech became a wholly owned subsidiary group of Roche on 25 March 2009. [27] Roche began vacating the NJ site in 2012, and sold it off in 2016. [28] Roche acquired Medingo Ltd. in April 2010, for $160 million [29] and BioImagene, Inc. in August for $100 million. [30]

  4. Genentech's great deal - AOL

    www.aol.com/news/2009-03-12-genentechs-great...

    Roche will finally buy Genentech (DNA) after months of fighting over a price for the acquisition. According to The Wall Street Journal (subscription required), "Swiss drug maker Roche Holding AG ...

  5. Tanox - Wikipedia

    en.wikipedia.org/wiki/Tanox

    Tanox became the first major acquisition of Genentech in an all-cash buyout deal (US$919 million) in August 2007 (Genentech itself became wholly owned by Roche in March 2009). The acquisition of Tanox has boosted Roche/Genentech's product pipeline substantially.

  6. Roche to complete $4.3 billion Spark deal as regulators give ...

    www.aol.com/news/roche-complete-4-3-billion...

    Roche is buying U.S.-based Spark to expand in gene therapy and boost its hemophilia A portfolio, where the Basel-based company's existing drug Hemlibra will surpass $1 billion sales in 2019.

  7. Roche settles US patent lawsuit against Biogen over ... - AOL

    www.aol.com/news/roche-settles-us-patent-lawsuit...

    Roche and its subsidiaries Genentech and Chugai Pharmaceutical jointly told the court without providing further details that they, Biogen and its manufacturer Bio-Thera had agreed to settle the ...

  8. Casirivimab/imdevimab - Wikipedia

    en.wikipedia.org/wiki/Casirivimab/imdevimab

    In May 2021, Roche India and Cipla announced that the medicine would be available in India for Rs 59,750 ($808.31) per dose. [ 32 ] In September 2021, the World Health Organization urged producers and governments to address the drug's high cost and called for technology sharing to enable the manufacture of biosimilar versions.

  9. Roche's Genentech buy could kill a technology leader

    www.aol.com/news/2009-03-12-does-roches...

    Swiss pharma giant Roche has reached an agreement with Genentech (DNA) to acquire at $95 a share the other 44 percent of the company that Roche doesn't already own. But Genentech -- which had all ...